The percentage of patients receiving medication for opioid use disorder in federally qualified health centers increased from 2017 to 2023.

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

With the first amyloid-targeting drug now approved for Alzheimer’s disease, Alnylam has presented preliminary clinical results with a new candidate that could potentially be dosed as ...

If an employee remains with a business after it has been sold or ownership has transferred, their years of service still count towards accrual of long service leave and the new owner becomes ...

Whether you have a little to say or a lot, your views, experiences and ideas will shape immediate steps and long-term changes: a new 10-Year Health Plan for the NHS. This is a once in a generation ...